The vax revolution will be filmed

As United States President Donald Trump learned on live TV this week, you can’t speed up the development of a vaccine simply by bullying scientists in public. Any coronavirus vaccine must be tested and tested and then tested again. 

One of his advisers admonished him: “You don’t want to rush and treat a million people and find out you’re making 900 000 of them worse.” As advice goes this is almost as wise as the well-known proverb, “Don’t contradict a moody head of state in public if you enjoy not being thrown into a nearby dungeon.” 

Nevertheless, speed does become important once a vaccine exists for Covid-19 or any other virus. A vaccine only stays viable for a certain period before it expires, so getting it where it needs to go is a race against the clock.

According to researchers writing in the journal Science Advances this week, using a thin-film membrane for oral administration means that a vaccine could be distributed far more quickly, widely and cheaply —and remain viable for longer — than vials of injectable liquid. 

And, in their paper, the researchers from the University of Austin in Texas describe how thin-film platforms can even allow vaccines to be safely stored for as long as three years — at room temperature. 


Cool story

The World Health Organisation (WHO) estimates that nearly 50% of freeze-dried and 25% of liquid vaccines produced worldwide are destroyed because of disruptions in the cold chain of supply logistics, “which entails transporting, storing and monitoring them at a recommended temperature from the point of production to the point of use”.

Even without those losses, it’s an extremely expensive enterprise. So much so that, in their paper, lead author Irnela Bajrovic and her colleagues make particular mention that the cost of distributing and administering vaccines often far outweighs the cost of making them.

According to a simulation model published in the journal Vaccine in 2015, it would cost $64-billion to introduce 18 vaccines to 94 countries within 10 years. Of that total cost, $38-billion would have to be spent on distribution and administration alone. 

Much of this goes to the cooling systems required for transportation. But the cost of transporting the sheer volume of the liquid vaccines is considerable. According to the WHO’s estimates, a batch of 350 000 single doses of liquid, injectable vaccines weighs nearly three tonnes — and that’s without the syringes. 

Bajrovic and her colleagues believe the benefits of a thin-film platform would essentially render these cost and weight issues meaningless. Vaccines that retain their efficacy over extended periods at room temperature mean that refrigeration is no longer the same concern. And according to the researcher’s calculations, 350 000 single doses of vaccine in a film-membrane format can be loaded into a box weighing just 3kg. 

So long, syringe

Any vaccine contained in a film would have to be developed specifically for mucosal absorption so that it could be administered orally —you would literally pop it into your mouth like a sweet. As the authors note, this delivery method is “needle free, eliminating the need for and associated costs of trained personnel for vaccine administration”.

Together, these cost and weight savings mean that once a vaccine is developed it could be distributed further and more quickly than any current supply chains can support — by orders of magnitude.

As Bajrovic et al point out, distribution and administration obstacles mean that each year tens of millions of infants around the world do not receive the basic immunisations routinely used in high-income or metropolitan areas. Shifting to thin-film delivery suddenly puts these areas in reach, with the potential to save many millions of people. 

Possibly even the disagreeable chap in the dungeon.

Subscribe to the M&G

These are unprecedented times, and the role of media to tell and record the story of South Africa as it develops is more important than ever.

The Mail & Guardian is a proud news publisher with roots stretching back 35 years, and we’ve survived right from day one thanks to the support of readers who value fiercely independent journalism that is beholden to no-one. To help us continue for another 35 future years with the same proud values, please consider taking out a subscription.

Matthew Du Plessis
Matthew du Plessis is the Mail & Guardian's former managing editor and chair of the Adamela Trust. He writes on the environment, dinosaurs, particle accelerators, evolutionary anthropology, genomics and super-continental fields of molten lava.

Related stories

Advertising

Subscribers only

Q&A Sessions: ‘I should have fought harder for SA vaccine’...

Professor Salim Abdool Karim talks to Nicolene de Wee about his responsibility as head of the ministerial advisory committee tasked with guiding the government’s response to the Covid-19 pandemic.

Do you have to take the Covid-19 vaccine or not?

The South African law does not make it mandatory for citizens to be vaccinated, and the same will apply for Covid-19 immunisation. But experts say people still have the responsibility not to act recklessly — and they should follow Covid-19 health protocols

More top stories

Zuma won’t appear before Zondo commission on Monday, say his...

Last year the commission asked the Constitutional Court to force the former president to appear. Although ruling has not been made, the summons remains valid, but Zuma’s lawyers say they won’t honour it

Molefe blames Ramaphosa for Eskom’s woes in statement to Zondo...

Brian Molefe guns for Cyril Ramaphosa, alleging that the president’s relationship with Glencore was only a ploy to siphon money out of Eskom

Death and anxiety rife at matric marking centres as schools...

Education department delays 2021 academic year as the Covid-19 death and infection rates rise rapidly, but assures 2020 matrics that results will be released on time

Zondo commission: Lynne Brown reportedly says ‘eish’ when told of...

More allegations against Jacob Zuma put before the state capture commission, as the questions the former president will have to answer when he appears next week continue to stack up
Advertising

press releases

Loading latest Press Releases…